Estradiol delivery by vaginal rings: potential for hormone replacement therapy

Area of Science:

• Endocrinology
• Gynecology
• Pharmacology

Background:

• Postmenopausal hormone therapy aims to alleviate symptoms and prevent bone loss.
• Estrogen replacement therapy (ERT) requires maintaining adequate estradiol blood levels.
• Vaginal delivery systems offer a potential alternative for consistent hormone administration.

Purpose of the Study:

• To assess if elastomeric vaginal rings achieve therapeutic estradiol blood levels for ERT.
• To correlate in vitro estradiol release with in vivo blood levels.
• To evaluate effects on lipid profiles, menopausal symptoms, and user satisfaction.

Main Methods:

• 21 postmenopausal women used vaginal rings releasing 100, 150, or 200 mcg/day of estradiol for 22 days.
• Serum estradiol levels were monitored every 3-4 days.
• Lipoprotein cholesterol, FSH levels, and vaginal cytology were assessed; symptom relief and satisfaction were surveyed.

Main Results:

• Mean serum estradiol levels ranged from 63 to 136 pg/ml, correlating with ring dosage.
• FSH levels decreased, and vaginal cell maturation increased, indicating estrogenic effects.
• Total and LDL cholesterol significantly decreased; HDL cholesterol remained unchanged. Menopausal symptoms were relieved, with high overall satisfaction despite initial discomfort.

Conclusions:

• Vaginal rings successfully deliver estradiol, achieving blood levels effective for managing menopausal symptoms and potentially preventing bone loss.
• The in vitro release rate accurately predicted in vivo estradiol levels across different dosages.
• Estradiol-releasing vaginal rings warrant further investigation as a viable option for hormone replacement therapy.